stacking8 min readエビデンス確認日： 2026年9月28日

How to Stack Nootropics Safely: Principles and Example Stacks

A practical guide to combining nootropic supplements for synergistic effects — including safe pairing rules, what to avoid, and three example stacks for different goals.

What is a nootropic stack?

A nootropic stack is a combination of two or more cognitive-enhancing compounds taken together to produce effects greater than either would alone. The concept comes from pharmacology — many drugs are more effective or better-tolerated in combination. The best-evidenced nootropic combination is L-Theanine + Caffeine: a meta-analysis of 11 RCTs found moderate improvements in alertness and attention-switching accuracy in the first 2 hours after dosing. L-theanine may reduce some of caffeine's stimulant side effects, though evidence for anxiety or jitteriness reduction specifically is mixed. Pre-formulated multi-ingredient stacks combine 8–11 ingredients designed to cover multiple cognitive pathways simultaneously.

The golden rule: one cholinergic source at a time

The most common stacking mistake is combining multiple cholinergic compounds without accounting for total acetylcholine load. Stacking Citicoline + Alpha-GPC + Huperzine A simultaneously gives your brain far more acetylcholine precursor and preservation than it needs — resulting in headaches, brain fog, and muscle tension (cholinergic overstimulation). Rule: choose one choline source (either Citicoline or Alpha-GPC, not both) and use Huperzine A separately with cycling. Some multi-ingredient stacks use Citicoline as their only choline source.

Safe pairing rules

Green pairings (generally safe to combine): L-Theanine + Caffeine; Bacopa + Phosphatidylserine; Lion's Mane + Citicoline; Rhodiola + L-Tyrosine; Ashwagandha + any of the above. Amber pairings (use with awareness): Huperzine A + any choline source — no clinically established dose adjustment exists, so do not improvise one; ask a healthcare professional. Stimulants + Ashwagandha — monitor for blunted response. Red pairings (avoid): Huperzine A + prescription cholinesterase inhibitors (e.g. Donepezil); Rhodiola or Tyrosine + MAOI antidepressants; Multiple acetylcholinesterase inhibitors simultaneously.

Example stack 1: focused work (daily driver)

Goal: sustained focus and memory for knowledge work. Acute layer: L-Theanine 200mg + Caffeine 100mg (or green tea). Cumulative layer: a multi-ingredient stack containing Citicoline, Bacopa, Lion's Mane, Phosphatidylserine, Rhodiola, and L-Tyrosine. Take the multi-ingredient stack daily; L-Theanine/Caffeine on demanding work days. No additional cholinergics needed. The doses come from single-ingredient trials — this combination has not been tested together in a clinical trial, so check with a clinician before starting it if you have a health condition or take medication.

Example stack 2: stress and resilience

Goal: cognitive performance under high-stress periods (exams, deadlines, travel). Foundation: Ashwagandha KSM-66 300mg twice daily. Acute support: Rhodiola Rosea 200mg in the morning (not evening — activating). Acute on-demand: L-Theanine 200mg before high-stakes meetings or presentations. Do not add caffeine-based stimulants on top of Rhodiola without testing individually first. The doses come from single-ingredient trials — this combination has not been tested together in a clinical trial, so check with a clinician before starting it if you have a health condition or take medication.

Example stack 3: long-term brain health (age 40+)

Goal: neuroprotection and maintenance of cognitive baseline with age. Core: Lion's Mane standardised fruiting body (e.g. from a specialist retailer) daily — healthy-adult trials used 1–1.8g per day; the 3g per day figure comes from a trial in mild cognitive impairment. Membrane support: Phosphatidylserine with a fat-containing meal. Positive single-ingredient trials mostly used 100–300mg per day (PMID 21103034, 20523044), while a review of the wider literature (PMID 25933483) cites 300–800mg per day; the benefit is most consistent in older adults. Cholinergic: Citicoline 250mg. This stack targets NGF production, membrane integrity, and acetylcholine availability — the three pathways most associated with age-related cognitive decline. The doses come from single-ingredient trials — this combination has not been tested together in a clinical trial, so check with a clinician before starting it if you have a health condition or take medication.

Nootropics in Japan

Building a stack from products bought outside Japan runs into two separate MHLW rules. First, an individual may bring in a personal-use quantity of medication-type goods without a license — MHLW's guidance sets this at up to two months' supply for a drug or quasi-drug and up to four months for a vitamin-type product. Second, MHLW separately lists specific ingredients common in nootropic stacks — including piracetam, aniracetam, oxiracetam, vinpocetine and DHEA — that require an advance import confirmation regardless of quantity, because of health-harm or misuse concerns when self-administered without a doctor.

The personal-use quantity allowance

MHLW's guidance on bringing medication into Japan states plainly: "There is no need for a License for individual's importing or bringing medication into Japan for personal use. An individual can import the following restricted quantities of medication without special procedures." The listed allowances include a drug or quasi-drug at up to two months' supply and a vitamin-type product at up to four months' supply. The same guidance adds that anything imported this way "must not be sold or given to others" — it covers a stack for one person's own use only.

Racetams and related ingredients need advance confirmation

A separate MHLW notice on personal imports of products claiming to enhance brain function found that many overseas medicines and supplements marketed this way contained ingredients used in prescription drugs. It lists named substances — among them piracetam, aniracetam, oxiracetam, nefiracetam, pramiracetam, levetiracetam, vinpocetine, adrafinil and DHEA — and states that when a product sold overseas contains one of these, obtaining an import confirmation (輸入確認証) in advance is required regardless of quantity (数量に関わらず), with one stated exception: a person entering Japan who carries the product for their own treatment during their stay (海外からの入国者が国内滞在中の自己の治療のために携帯して輸入する場合を除いて) before it may be personally imported at all.

Products in Japan

Consumer Affairs Agency (FFC)

How much of a nootropic supplement can I personally import into Japan without a license?

MHLW's guidance sets the general allowance at "Up to 2 months' supply" for a drug or quasi-drug-type product and "Up to 4 months' supply" for a vitamin-type product, without needing special import procedures — but this general allowance does not apply to the specific ingredients MHLW separately restricts (see below).

Can I bring piracetam, aniracetam, or vinpocetine into Japan as part of a personal stack?

MHLW's 2018 notice (revised 2020) on brain-function-enhancement products names these among substances requiring an import confirmation certificate before entry regardless of quantity (the only stated exception is a traveller carrying the product for their own treatment during their stay), because unsupervised self-use of them was judged to carry a real risk of health harm or misuse without a doctor's prescription or instruction.

Is an imported nootropic stack covered if it causes a health problem?

No. MHLW's health-food guidance notes that medication personally imported from overseas is excluded from Japan's Adverse Drug Reaction Relief System, the state fund that covers medical costs for people harmed despite proper use of a domestically supplied medicine — a gap worth weighing before importing a multi-ingredient stack.

Prefecture guides

Sources: MHLW — Importing or Bringing Medication into Japan for Personal Use · MHLW (Kinki Regional Bureau of Health and Welfare) — 脳機能の向上等を標ぼうする医薬品等を個人輸入する場合の取扱いについて (Handling of personal imports of medicines etc. claiming to enhance brain function) · MHLW / National Institute of Health and Nutrition — 健康食品の正しい利用法 (Correct Use of Health Foods) · MHLW (Kinki Regional Bureau) — traveller exception in the brain-function import notice

Regulatory note

本ページは教育目的の編集コンテンツであり、医学的助言を構成するものではありません。日本国内で販売される機能性表示食品（FFC）および特定保健用食品（FOSHU）は、消費者庁への届出または許可を必要とします。届出のない輸入品については、日本の薬機法（旧薬事法）の下で疾病治療を示唆する表現は規制されます。サプリメントを開始する前に、必ず資格のある医療専門家にご相談ください。This page is editorial and not medical advice. Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) sold in Japan require notification or approval from the Consumer Affairs Agency. Imported products without notification cannot make disease-treatment claims under the Pharmaceuticals and Medical Devices (PMD) Act. Note: In July 2026, the Consumer Affairs Agency (CAA) opened a public comment period (Notice No. 235080088, closes 30 July 2026) on proposed revisions to permitted claim wording for FFC-notified ingredients including DHA, phosphatidylserine, and NMN; compliant claim language may require updating once the final Cabinet Office Order is published. Consult a qualified healthcare professional before starting any supplement.

出典 (9)展開

← Back to Guides